cytochrome P450 family 2 subfamily C member 19
E1560359
UNEXPLORED
Cytochrome P450 family 2 subfamily C member 19 (CYP2C19) is a liver enzyme that metabolizes various clinically important drugs, including proton pump inhibitors, antidepressants, and the antiplatelet agent clopidogrel, with genetic variants significantly affecting individual drug response.
All labels observed (1)
| Label | Occurrences |
|---|---|
| cytochrome P450 family 2 subfamily C member 19 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22888987 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: cytochrome P450 family 2 subfamily C member 19 Context triple: [CYP2C19, fullName, cytochrome P450 family 2 subfamily C member 19]
-
A.
CYP2J2
CYP2J2 is a human cytochrome P450 enzyme primarily expressed in the heart and other tissues, involved in the metabolism of various drugs and endogenous fatty acids.
-
B.
CYP3A4
CYP3A4 is a major human liver and intestinal enzyme of the cytochrome P450 family responsible for metabolizing a wide range of drugs and xenobiotics.
-
C.
cytochrome P450 superfamily
The cytochrome P450 superfamily is a large and diverse group of heme-containing enzymes that catalyze the oxidation of a wide variety of endogenous compounds and xenobiotics, playing key roles in drug metabolism and biosynthesis of hormones and lipids.
-
D.
CYP1 family
The CYP1 family is a group of cytochrome P450 enzymes involved in the metabolism of xenobiotics and endogenous compounds, including many drugs and environmental chemicals.
-
E.
CYP1A2
CYP1A2 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs and xenobiotics.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: cytochrome P450 family 2 subfamily C member 19 Target entity description: Cytochrome P450 family 2 subfamily C member 19 (CYP2C19) is a liver enzyme that metabolizes various clinically important drugs, including proton pump inhibitors, antidepressants, and the antiplatelet agent clopidogrel, with genetic variants significantly affecting individual drug response.
-
A.
CYP2J2
CYP2J2 is a human cytochrome P450 enzyme primarily expressed in the heart and other tissues, involved in the metabolism of various drugs and endogenous fatty acids.
-
B.
CYP3A4
CYP3A4 is a major human liver and intestinal enzyme of the cytochrome P450 family responsible for metabolizing a wide range of drugs and xenobiotics.
-
C.
cytochrome P450 superfamily
The cytochrome P450 superfamily is a large and diverse group of heme-containing enzymes that catalyze the oxidation of a wide variety of endogenous compounds and xenobiotics, playing key roles in drug metabolism and biosynthesis of hormones and lipids.
-
D.
CYP1 family
The CYP1 family is a group of cytochrome P450 enzymes involved in the metabolism of xenobiotics and endogenous compounds, including many drugs and environmental chemicals.
-
E.
CYP1A2
CYP1A2 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs and xenobiotics.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.